DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed ...
The global Embolic Protection Devices Market is valued at $601 million in 2023 and is projected to reach $1,250 million by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback